THE ATG BASED MYELOABLATIVE CONDITIONING REGIMEN IS EFFECTIVE IN PATIENTS WITH RELAPSED OR HIGH-RISK T CELL LYMPHOMA

被引：0
|
作者：
Jun, Y. [1 ,2 ]
Chun, W. [1 ]
Shike, Y. [1 ]
Jieling, J. [1 ]
Liping, W. [1 ]
Yu, C. [1 ]
Jun, Y. [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Affiliated Shanghai Peoples Hosp 1, Hematol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Affiliated Shanghai Peoples Hosp 1, Hematolog, Shanghai, Peoples R China
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B1700
引用
收藏
页码：664 / 665
页数：2
相关论文
共 50 条
  • [1] Pentostatin based non-myeloablative conditioning regimen in patients with high-risk hematologic malignancy.
    Bayer, RL
    Feldman, EJ
    Coleman, M
    Roboz, G
    Leonard, J
    Michaeli, J
    Schuster, MW
    BLOOD, 2000, 96 (11) : 327B - 327B
  • [2] MCVAC as an effective non-TBI conditioning regimen for autologous stem cell transplantation in patients with high-risk lymphoma
    Watanabe, R
    Okamoto, S
    Mori, T
    Asahi, A
    Ikeda, Y
    BONE MARROW TRANSPLANTATION, 2001, 27 : S266 - S267
  • [3] Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamid and ATG for allogeneic stem cell transplantation in patients with relapsed or high-risk acute myeloic leukaemia
    Chemnitz, J.
    Holtik, U.
    Theurich, S.
    Shimabokuro-Vornhagen, A.
    Hallek, M.
    Scheid, C.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S404 - S404
  • [4] Intermediate intensity conditioning regimen containing FLAMSA, Treosulfan, Cyclophosphamid and ATG for allogeneic stem cell transplantation in patients with relapsed or high-risk acute myeloic leukaemia
    Chemnitz, J.
    Holtik, U.
    Theurich, S.
    Shimabokuro-Vomhagen, A.
    Krause, A.
    Hallek, M.
    Scheid, C.
    ONKOLOGIE, 2010, 33 : 166 - 166
  • [5] Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia
    Chemnitz, Jens Marcus
    von Lilienfeld-Toal, Marie
    Holtick, Udo
    Theurich, Sebastian
    Shimabukuro-Vornhagen, Alexander
    Krause, Anke
    Brossart, Peter
    Hallek, Michael
    Scheid, Christof
    ANNALS OF HEMATOLOGY, 2012, 91 (01) : 47 - 55
  • [6] Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia
    Jens Marcus Chemnitz
    Marie von Lilienfeld-Toal
    Udo Holtick
    Sebastian Theurich
    Alexander Shimabukuro-Vornhagen
    Anke Krause
    Peter Brossart
    Michael Hallek
    Christof Scheid
    Annals of Hematology, 2012, 91 : 47 - 55
  • [7] No-Myeloablative Conditioning Regimen Cyclosphophamide-Fludarabine-ATG (Cy-Flu-ATG) Results in Better Overall Survival Compared with Myeloablative Doses of Cy with or without ATG, in High-Risk Bone Marrow Failure Syndromes (BMFS) Patients
    Abello, Virginina
    Villamizar, Licet
    Pedraza, Enrique
    Esguerra, Herman
    Rosales, Carmen
    Rosales, Manuel
    Figueroa, Javier
    Cordoba, Iris
    Linares, Adriana
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S212 - S212
  • [8] Myeloablative Conditioning Regimen in Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide in Children With High-risk Hematologic Malignancies
    Dufort y Alvarez, Gustavo
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2022, 44 (06) : E930 - E938
  • [9] Allogeneic stem cell transplantation as treatment for relapsed and high-risk peripheral T-cell lymphoma
    O'Leary, Hilary M.
    Savage, Kerry J.
    Toze, Cynthia L.
    Connors, Joseph M.
    Gascoyne, Randy D.
    Abou Mourad, Yasser
    Barnett, Michael J.
    Forrest, Donna L.
    Hogge, Donna E.
    Lavoie, Julye
    Nantel, Stephen H.
    Nevill, Thomas J.
    Shepherd, John D.
    Smith, Clayton
    Sutherland, Heather J.
    Voss, Nicholas
    Brinkmann, Ryan
    Song, Kevin
    BLOOD, 2007, 110 (11) : 893A - 893A
  • [10] High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma
    Di Ianni, Mauro
    Ballanti, Stelvio
    Iodice, Giuseppe
    Reale, Antonia
    Falzetti, Franca
    Minelli, Olivia
    Serio, Gabriella
    Martelli, Massimo F.
    Dammacco, Franco
    Vacca, Angelo
    Ria, Roberto
    HEMATOLOGY, 2012, 17 (01) : 23 - 27
12345